June 21, 2015 | Teva Pharmaceutical Industries and Microchips Biotech announced a partnership to explore integrating Microchip’s implantable drug delivery device into Teva’s products. The goal of such a partnership would be to improve the outcomes for patients that engage in chronic therapy. Microchip’s innovative technology can administer drugs over a period of months to years, releasing the drugs at pre-determined times.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments